SOADOR
MRNA icon

State of Alaska Department of Revenue’s Moderna MRNA Stock Holding History

State of Alaska Department of Revenue’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Sell
34,601
-206
-0.6% -$10.7K 0.02% 609
2026
Q1 		$1.77M Buy
34,807
+1,045
+3% +$48.8K 0.02% 771
2025
Q4 		$995K Sell
33,762
-3,190
-9% -$86.7K 0.01% 1078
2025
Q3 		$954K Sell
36,952
-1,172
-3% -$32.7K 0.01% 1103
2025
Q2 		$1.05M Sell
38,124
-1,525
-4% -$40.2K 0.01% 1020
2025
Q1 		$1.12M Sell
39,649
-4,234
-10% -$150K 0.01% 953
2024
Q4 		$1.82M Sell
43,883
-685
-2% -$32.7K 0.02% 743
2024
Q3 		$2.98M Buy
44,568
+3,090
+7% +$284K 0.03% 550
2024
Q2 		$4.92M Sell
41,478
-21,020
-34% -$2.66M 0.06% 356
2024
Q1 		$6.66M Sell
62,498
-6,755
-10% -$681K 0.08% 271
2023
Q4 		$6.89M Sell
69,253
-3,365
-5% -$283K 0.08% 263
2023
Q3 		$7.5M Sell
72,618
-1,085
-1% -$121K 0.09% 220
2023
Q2 		$8.95M Sell
73,703
-3,703
-5% -$494K 0.11% 197
2023
Q1 		$11.9M Sell
77,406
-969
-1% -$160K 0.14% 153
2022
Q4 		$14.1M Sell
78,375
-3,321
-4% -$543K 0.18% 119
2022
Q3 		$9.66M Sell
81,696
-6,766
-8% -$1.03M 0.13% 164
2022
Q2 		$12.6M Buy
88,462
+35,190
+66% +$5.03M 0.15% 124
2022
Q1 		$9.18M Sell
53,272
-1,547
-3% -$260K 0.1% 231
2021
Q4 		$13.9M Sell
54,819
-2,092
-4% -$612K 0.13% 155
2021
Q3 		$21.9M Buy
+56,911
New +$21M 0.22% 88
2019
Q3 		– Sell
-3,284
Closed -$47K – 1708
2019
Q2 		$47K Buy
3,284
+59
+2% +$1.27K ﹤0.01% 1644
2019
Q1 		$64K Buy
+3,225
New +$59.9K ﹤0.01% 1642

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State of Alaska Department of Revenue's MRNA Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Moderna (MRNA) stake by 0.59% in Q2 2026, selling an estimated $10.7K and leaving 34,601 shares worth $2.42M. The position accounts for 0.02% of the portfolio, ranked #609.

State of Alaska Department of Revenue first reported a position in MRNA in Q1 2019 and has held it in 22 quarters since. The position peaked at $21.9M in Q3 2021. 545 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • State of Alaska Department of Revenue held 34,601 shares of Moderna worth $2.42M as of Q2 2026.
  • State of Alaska Department of Revenue sold 206 Moderna shares in Q2 2026, an estimated $10.7K.
  • Moderna made up 0.02% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #609 holding.
  • State of Alaska Department of Revenue first reported a position in Moderna in Q1 2019 and has held it in 22 quarters since.
  • State of Alaska Department of Revenue's Moderna position peaked at $21.9M in Q3 2021.
  • 545 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.